Hairy Cell Leukemia

Hairy cell leukemia is a type of blood cancer involving the excess production of lymphocytes. Here is the latest research on hairy cell leukemia.

September 18, 2021

Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.

Blood Reviews
Robert J Kreitman, Evgeny Arons
August 13, 2021

Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases.

Clinical Lymphoma, Myeloma & Leukemia
Bella V BidermanAndrey B Sudarikov
August 12, 2021
Open Access

In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia.

Frontiers in Oncology
Alexia VereertbrugghenPablo Elías Morande
August 10, 2021
Case Report
Open Access

A Rare Case of a Patient With Hairy Cell Leukemia Developing Blastoid Marginal Zone B-Cell Lymphoma.

Yeshanew TeklieMadhavi Venigalla
August 7, 2021
Open Access

The Biology of Classic Hairy Cell Leukemia.

International Journal of Molecular Sciences
Jan-Paul BohnDominik Wolf
August 7, 2021
Open Access

Changes of Dentition State in Leukemic Patients during Chemotherapy.

International Journal of Environmental Research and Public Health
Maja PtasiewiczRenata Chałas
August 2, 2021

Pair-Correlated Imaging of Cl + CH3D(v4, v1-I, v1-II = 1, |jK⟩) → CH2D(vi) + HCl(v).

The Journal of Physical Chemistry. a
Huilin Pan, Kopin Liu
July 20, 2021

Management of Relapsed Hairy Cell Leukemia: A Systematic Review of Novel Agents and Targeted Therapies.

Clinical Lymphoma, Myeloma & Leukemia
Raheel SiddiquiFaiz Anwer
July 16, 2021

Hairy cell leukemia: a brief update on current knowledge and treatment prospects.

Current Opinion in Oncology
Anna Puła, Tadeusz Robak
July 13, 2021
Open Access

Patients with relapsed/refractory hairy-cell leukemia.

Cancer Reports
Jérôme Paillassa, Xavier Troussard
July 10, 2021

The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience.

American Journal of Hematology
Alessandro BroccoliPier Luigi Zinzani
July 3, 2021
Open Access

Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox.

Journal of Clinical Medicine
Tadeusz RobakRobert J Kreitman
June 22, 2021
Open Access

Isolated Single-Atomic Cu Catalyst Supported on P-doped Carbon for Hydrochlorination of Acetylene

Ting WangXiaonian Li
June 5, 2021
Open Access

Successful treatment of hairy cell leukemia variant with obinutuzumab.

Annals of Hematology
Diana Al-SarayfiMarcel Nijland
May 26, 2021

Moxetumomab pasudotox as re-treatment for heavily-pretreated relapsed hairy cell leukemia.

Leukemia & Lymphoma
Ilana R YurkiewiczRobert J Kreitman
May 24, 2021

[Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?]

Bulletin du cancer
Xavier TroussardJérôme Paillassa

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

© 2021 Meta ULC. All rights reserved